IMMUNOMODULATOR METALLOPEPTIDES (IMMPS) AND COMPOSITIONS CONTAINING SAME

The present invention relates to the field of human and veterinary medicine. The invention solves the problem associated with the lack of an agent for improving the immune response in immunosuppressed individuals, or with autoimmunity problems as well as infections; reducing the effects of the stres...

Full description

Saved in:
Bibliographic Details
Main Authors MARTINEZ DE LOS RIOS CORSINO ABRIL ARIANNA, REYES ESPARZA JORGE ALBERTO, TORRES AGUILAR LORENA JULIETA, BADILLO JIMENEZ ANA LAURA, ARJONA CANUL CARLOS ANTONIO, RODRIGUEZ FRAGOSO MARIA DE LOURDES, MARTINEZ OSUNA LORENZO ULISES, MORALES ROJAS HUGO
Format Patent
LanguageEnglish
Published 14.05.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to the field of human and veterinary medicine. The invention solves the problem associated with the lack of an agent for improving the immune response in immunosuppressed individuals, or with autoimmunity problems as well as infections; reducing the effects of the stress, combating tissue fibrosis; the need for anti-inflammatory agents; treatments for acute and chronic hepatitis, treatments against malignant processes and metastasis, as well as thrombocytopenia, both in humans and animals. The present invention comprises a molecular complex formed by a metallic ion and a peptide as novel compound, which is denominated as an immunomodulator metallopeptide hereafter abbreviated as IMMP. Claims also include the process for obtaining the complex, the use of the metallopeptide for producing a therapeutic or nutraceutic agent, and the use of that agent in humans and animals.
Bibliography:Application Number: US201114348326